Structure of the σ1 Receptor and Its Ligand Binding Site-Reference-Cited by-同舟云学术

Structure of the σ1 Receptor and Its Ligand Binding Site

Published:2013-09-10 Issue:24 Volume:56 Page:9809-9819
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Brune Stefanie¹,Pricl Sabrina²³,Wünsch Bernhard¹

Affiliation:

1. Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstraße 48, D-48149 Münster, Germany

2. Molecular Simulation Engineering (MOSE) Laboratory, Department of Engineering and Architecture (DIA), University of Trieste, Via Valerio 10, 34127 Trieste, Italy

3. Research Unit MOSE-DEA, University of Trieste, National Interuniversity Consortium for Material Science and Technology (INSTM), 34127 Trieste, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm400660u

Reference84 articles.

1. Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog

2. Naloxone-inaccessible sigma receptor in rat central nervous system.

3. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors

4. A proposal for the classification of sigma binding sites

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The proof of concept of 2-{3-[N-(1-benzylpiperidin-4-yl)propyl]amino}-6-[N-methyl-N-(prop-2-yn-1-yl)amino]-4-phenylpyridine-3,5-dicarbonitrile for the therapy of neuropathic pain;Bioorganic Chemistry;2024-09

2. Exploring the Association between Schizophrenia and Cardiovascular Diseases: Insights into the Role of Sigma 1 Receptor;Physiological Research;2023-07-31

3. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents;ACS PHARMACOL TRANSL;2022

4. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents;ACS Pharmacology & Translational Science;2022-10-12

5. Haloperidol Prevents Oxytosis/Ferroptosis by Targeting Lysosomal Ferrous Ions in a Manner Independent of Dopamine D2 and Sigma-1 Receptors;ACS Chemical Neuroscience;2022-09-01